1. Levin TR, Schmittdiel JA, Kunz K, Henning JM, Henke CJ, Colby CJ, Selby JV (1997) Costs of acid reflux disorders to a health maintenance organization. Am J Med 103: 520–528
2. Lair TJ, Fu Q, Anderson DR, Crawley JA (1998) Utilisation and expenditures in the treatment of patients with gastroesophageal reflux disease. Dis Manage Health Outcome 4(6): 325–336
3. Agreus L, Borgquist L (2002) The cost of gastrooesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 20(5): 347–355
4. Schwenkglenks M, Marbet UA, Szucs TD (2004) Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study. Soz Praventivmed 49(1): 51–61
5. Wahlqvist P et al (1999) Measuring lost productivity in patients with gastro-oesophageal reflux disease using a productivity questionnaire (WPAI-GORD). Medical Decision Making 19: 532–536